Ecological interventionist causal models in psychosis: Targeting psychological mechanisms in daily life

Schizophrenia Bulletin

Volumn 42, Issue 2, 2016, Pages 264-269

  Reininghaus, Ulrich ^a,b   Depp, Colin A ^c,d   Myin Germeys, Inez ^e  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Causal criteria; Ecological momentary intervention; Experience sampling methodology; Psychological intervention; Schizophrenia

Indexed keywords

ARTICLE; ASSOCIATION; DAILY LIFE ACTIVITY; DISEASE EXACERBATION; HUMAN; INTERVENTION STUDY; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SOCIAL ENVIRONMENT; SOCIAL INTERACTION; PATHOPHYSIOLOGY; PSYCHOLOGICAL MODEL; PSYCHOLOGY; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

HUMANS; MODELS, PSYCHOLOGICAL; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84964854483     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbv193     Document Type: Article

References (69)

1. Garety PA, Bebbington P, Fowler D, Freeman D, Kuipers E. Implications for neurobiological research of cognitive models of psychosis: A theoretical paper. Psychol Med. 2007;37:1377-1391.
2. Howes OD, Murray RM. Schizophrenia: An integrated sociodevelopmental- cognitive model. Lancet. 2014;383:1677-1687.
3. Morgan C, Charalambides M, Hutchinson G, Murray RM. Migration, ethnicity, and psychosis: Toward a sociodevelopmental model. Schizophr Bull. 2010;36:655-664.
4. Reininghaus U, Morgan C. Integrated models in psychiatry: The state of the art. Soc Psychiatry Psychiatr Epidemiol. 2014;49:1-2.
5. Akdeniz C, Tost H, Meyer-Lindenberg A. The neurobiology of social environmental risk for schizophrenia: An evolving research field. Soc Psychiatry Psychiatr Epidemiol. 2014;49:507-517.
6. Bentall RP, de Sousa P, Varese F, et al. From adversity to psychosis: pathways and mechanisms from specific adversities to specific symptoms. Soc Psychiatry Psychiatr Epidemiol. 2014;49:1011-1022.
7. Freeman D, Garety P. Advances in understanding and treating persecutory delusions: A review. Soc Psychiatry Psychiatr Epidemiol. 2014;49:1179-1189.
8. Morgan C, Reininghaus U, Fearon P, et al. Modelling the interplay between childhood and adult adversity in pathways to psychosis: initial evidence from the AESOP study. Psychol Med. 2014;44:407-419.
9. Pishva E, Kenis G, van den Hove, D, et al. The epigenome and postnatal environmental influences in psychotic disorders. Soc Psychiatry Psychiatr Epidemiol. 2014;49:337-348.
10. Reininghaus U, Craig TK, Fisher HL, et al. Ethnic identity, perceptions of disadvantage, and psychosis: findings from the AESOP study. Schizophr Res. 2010;124:43-48.
11. Reininghaus U, Morgan C, Simpson J, et al. Unemployment, social isolation, achievement-expectation mismatch and psychosis: findings from the AESOP Study. Soc Psychiatry Psychiatr Epidemiol. 2008;43:743-751.
12. Cannon TD, Keller MC. Endophenotypes in the genetic analyses of mental disorders. Annu Rev Clin Psychol. 2006;2:267-290.
13. Myin-Germeys I, Oorschot M, Collip D, Lataster J, Delespaul P, van Os, J. Experience sampling research in psychopathology: opening the black box of daily life. Psychol Med. 2009;39:1533-1547.
14. Myin-Germeys I, Birchwood M, Kwapil T. From environment to therapy in psychosis: A real-world momentary assessment approach. Schizophr Bull. 2011;37:244-247.
15. Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol. 2008;4:1-32.
16. Moffitt TE, Caspi A, Rutter M. Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry. 2005;62:473-481.
17. Collip D, Nicolson NA, Lardinois M, Lataster T, van Os, J, Myin-Germeys I; G.R.O.U.P. Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychol Med. 2011;41:2305-2315.
18. Lataster T, Wichers M, Jacobs N, et al. Does reactivity to stress cosegregate with subclinical psychosis? A general population twin study. Acta Psychiatr Scand. 2009;119:45-53.
19. Myin-Germeys I, van Os, J. Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clin Psychol Rev. 2007;27:409-424.
20. Myin-Germeys I, van Os J, Schwartz JE, Stone AA, Delespaul PA. Emotional reactivity to daily life stress in psychosis. Arch Gen Psychiatry. 2001;58:1137-1144.
21. Oorschot M, Kwapil T, Delespaul P, Myin-Germeys I. Momentary assessment research in psychosis. Psychol Assess. 2009;21:498-505.
22. Fusar-Poli P, Borgwardt S, Bechdolf A, et al. The psychosis high-risk state: A comprehensive state-of- The- Art review. JAMA Psychiatry. 2013;70:107-120.
23. Yung AR, Yuen HP, McGorry PD, et al. Mapping the onset of psychosis: The Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry. 2005;39:964-971.
24. Palmier-Claus JE, Dunn G, Lewis SW. Emotional and symptomatic reactivity to stress in individuals at ultra-high risk of developing psychosis. Psychol Med. 2012;42:1003-1012.
25. Reininghaus U, Kempton MJ, Valmaggia L, et al. Stress sensitivity, aberrant salience, and threat anticipation in early psychosis: An experience sampling study. Schizophr Bull. In press.
26. Lataster T, Collip D, Lardinois M, van Os, J, Myin-Germeys I. Evidence for a familial correlation between increased reactivity to stress and positive psychotic symptoms. Acta Psychiatr Scand. 2010;122:395-404.
27. Oorschot M, Lataster T, Thewissen V, et al. Emotional experience in negative symptoms of schizophrenia-no evidence for a generalized hedonic deficit. Schizophr Bull. 2013;39:217-225.
28. Brown LH, Silvia PJ, Myin-Germeys I, Kwapil TR. When the need to belong goes wrong: The expression of social anhedonia and social anxiety in daily life. Psychol Sci. 2007;18:778-782.
29. Husky MM, Grondin OS, Swendsen JD. The relation between social behavior and negative affect in psychosis-prone individuals: An experience sampling investigation. Eur Psychiatry. 2004;19:1-7.
30. Myin-Germeys I, Delespaul PA, deVries MW. Schizophrenia patients are more emotionally active than is assumed based on their behavior. Schizophr Bull. 2000;26:847-854.
31. Gard DE, Kring AM, Gard MG, Horan WP, Green MF. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res. 2007;93:253-260.
32. Gard DE, Sanchez AH, Cooper K, Fisher M, Garrett C, Vinogradov S. Do people with schizophrenia have difficulty anticipating pleasure, engaging in effortful behavior, or both? J Abnorm Psychol. 2014;123:771-782.
33. Sanchez AH, Lavaysse LM, Starr JN, Gard DE. Daily life evidence of environment-incongruent emotion in schizophrenia. Psychiatry Res. 2014;220:89-95.
34. Palmier-Claus JE, Dunn G, Taylor H, Morrison AP, Lewis SW. Cognitive-self consciousness and metacognitive beliefs: Stress sensitization in individuals at ultra-high risk of developing psychosis. Br J Clin Psychol. 2013;52:26-41.
35. Palmier-Claus JE, Dunn G, Morrison AP, Lewis SW. The role of metacognitive beliefs in stress sensitisation, self-esteem variability, and the generation of paranoia. Cogn Neuropsychiatry. 2011;16:530-546.
36. Thewissen V, Bentall RP, Lecomte T, van Os, J, Myin-Germeys I. Fluctuations in self-esteem and paranoia in the context of daily life. J Abnorm Psychol. 2008;117:143-153.
37. Thewissen V, Bentall RP, Oorschot M, et al. Emotions, selfesteem, and paranoid episodes: An experience sampling study. Br J Clin Psychol. 2011;50:178-195.
38. Lardinois M, Myin-Germeys I, Bak M, Mengelers R, van Os, J, Delespaul PA. The dynamics of symptomatic and nonsymptomatic coping with psychotic symptoms in the flow of daily life. Acta Psychiatr Scand. 2007;116:71-75.
39. Depp CA, Ceglowski J, Wang VC, et al. Augmenting psychoeducation with a mobile intervention for bipolar disorder: A randomized controlled trial. J Affect Disord. 2015;174:23-30.
40. Depp CA, Stricker JL, Zagorsky D, et al. Disability and selfmanagement practices of people with bipolar disorder: A webbased survey. Commun Ment Health J. 2009;45(3):179-187.
41. Peters E, Lataster T, Greenwood K, et al. Appraisals, psychotic symptoms and affect in daily life. Psychol Med. 2012;42:1013-1023.
42. Ben-Zeev D, Ellington K, Swendsen J, Granholm E. Examining a cognitive model of persecutory ideation in the daily life of people with schizophrenia: A computerized experience sampling study. Schizophr Bull. 2011;37:1248-1256.
43. Ben-Zeev D, Morris S, Swendsen J, Granholm E. Predicting the occurrence, conviction, distress, and disruption of different delusional experiences in the daily life of people with schizophrenia. Schizophr Bull. 2012;38:826-837.
44. Schwartz S, Susser E. Relationships among causes. In: Susser E, Schwartz S, Morabia A, Bromet E, eds. Psychiatric Epidemiology: Searching for Causes of Mental Disorders. Oxford, UK: Oxford University Press; 2006:62-74.
45. Maclure M. Popperian refutation in epidemiology. Am J Epidemiol. 1985;121:343-350.
46. Susser M. What is a cause and how do we know one? A grammar for pragmatic epidemiology. Am J Epidemiol. 1991;133:635-648.
47. Kendler KS, Campbell J. Interventionist causal models in psychiatry: repositioning the mind-body problem. Psychol Med. 2009;39:881-887.
48. Freeman D. Improving cognitive treatments for delusions. Schizophr Res. 2011;132:135-139.
49. Heron KE, Smyth JM. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br J Health Psychol. 2010;15:1-39.
50. Emsley R, Dunn G, White IR. Mediation and moderation of treatment effects in randomised controlled trials of complex interventions. Stat Methods Med Res. 2010;19:237-270.
51. Insel TR, Gogtay N. National Institute of Mental Health clinical trials: new opportunities, new expectations. JAMA Psychiatry. 2014;71:745-746.
52. Hotopf M, Churchill R, Lewis G. Pragmatic randomised controlled trials in psychiatry. Br J Psychiatry. 1999;175:217-223.
53. Heinz A, Deserno L, Reininghaus U. Urbanicity, social adversity and psychosis. World Psychiatry. 2013;12:187-197.
54. Kirkbride JB, Jones PB. The prevention of schizophrenia- what can we learn from eco-epidemiology? Schizophr Bull. 2011;37:262-271.
55. March D, Hatch SL, Morgan C, et al.. Psychosis and place. Epidemiol Rev. 2008;30:84-100.
56. Hotopf M. The pragmatic randomised controlled trial. Advances in Psychiatric Treatment. 2002;2002:326-333.
57. Reininghaus U, Böhnke J, Hosang G, et al. Probing the boundaries of the Kraepelinian dichotomy: Evidence for a transdiagnostic psychosis spectrum encompassing schizophrenia and bipolar disorder. Br J Psychiatry. In press.
58. Lasalvia A, Bonetto C, Tansella M, Stefani B, Ruggeri M. Does staff-patient agreement on needs for care predict a better mental health outcome? A 4-year follow-up in a community service. Psychol Med. 2008;38:123-133.
59. Reininghaus U, McCabe R, Slade M, Burns T, Croudace T, Priebe S. The validity of patient- And clinician-rated measures of needs and the therapeutic relationship in psychosis: A pooled analysis. Psychiatry Res. 2013;209:711-720.
60. Reininghaus U, Priebe S. Measuring patient-reported outcomes in psychosis: conceptual and methodological review. Br J Psychiatry. 2012;201:262-267.
61. Rose D, Thornicroft G, Slade M. Who decides what evidence is? Developing a multiple perspectives paradigm in mental health. Acta Psychiatr Scand Suppl. 2006:109-114.
62. Birchwood M, Trower P. The future of cognitive-behavioural therapy for psychosis: not a quasi-neuroleptic. Br J Psychiatry. 2006;188:107-108.
63. Garety PA, Fowler DG, Freeman D, Bebbington P, Dunn G, Kuipers E. Cognitive-behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. Br J Psychiatry. 2008;192:412-423.
64. Wykes T. Cognitive-behaviour therapy and schizophrenia. Evid Based Ment Health. 2014;17:67-68.
65. Tatara N, Arsand E, Skrøvseth SO, Hartvigsen G. Long- Term engagement with a mobile self-management system for people with type 2 diabetes. JMIR Mhealth Uhealth. 2013;1:e1.
66. Wolin KY, Steinberg DM, Lane IB, et al. Engagement with eHealth self-monitoring in a primary care-based weight management intervention. PLoS One. 2015;10:e0140455.
67. Granholm E, Ben-Zeev D, Link PC, Bradshaw KR, Holden JL. Mobile Assessment and Treatment for Schizophrenia (MATS): A pilot trial of an interactive text-messaging intervention for medication adherence, socialization, and auditory hallucinations. Schizophr Bull. 2012;38:414-425.
68. Ben-Zeev D, Brenner CJ, Begale M, Duffecy J, Mohr DC, Mueser KT. Feasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophrenia. Schizophr Bull. 2014;40:1244-1253.
69. Steinhart H, Vaessen T, Batink T, Myin-Germeys I. ACT in daily life: A momentary intervention approach.